0001938571-26-000004.txt : 20260622 0001938571-26-000004.hdr.sgml : 20260622 20260622164038 ACCESSION NUMBER: 0001938571-26-000004 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260622 DATE AS OF CHANGE: 20260622 EFFECTIVENESS DATE: 20260622 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ADAPTIN BIO, INC. CENTRAL INDEX KEY: 0001938571 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences EIN: 881566415 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-568890 FILM NUMBER: 261107640 BUSINESS ADDRESS: STREET 1: 3540 TORINGDON WAY STREET 2: SUITE 200, #250 CITY: CHARLOTTE STATE: NC ZIP: 28277 BUSINESS PHONE: (888) 609-1498 MAIL ADDRESS: STREET 1: 3540 TORINGDON WAY STREET 2: SUITE 200, #250 CITY: CHARLOTTE STATE: NC ZIP: 28277 FORMER COMPANY: FORMER CONFORMED NAME: Unite Acquisition 1 Corp. DATE OF NAME CHANGE: 20220719 D/A 1 primary_doc.xml X0708 D/A LIVE 0001938571 ADAPTIN BIO, INC. 3540 TORINGDON WAY SUITE 200, #250 CHARLOTTE NC NORTH CAROLINA 28277 (888) 609-1498 DELAWARE Unite Acquisition 1 Corp. Corporation true 2022 Michael Roberts c/o Adaptin Bio, Inc. 3540 TORINGDON WAY, SUITE 200, #250 Charlotte NC NORTH CAROLINA 28277 Executive Officer Director President and Chief Executive Officer Patrick Gallagher c/o Adaptin Bio, Inc. 3540 TORINGDON WAY, SUITE 200, #250 Charlotte NC NORTH CAROLINA 28277 Director J. Nick Riehle c/o Adaptin Bio, Inc. 3540 TORINGDON WAY, SUITE 200, #250 Charlotte NC NORTH CAROLINA 28277 Director Anthony Zook c/o Adaptin Bio, Inc. 3540 TORINGDON WAY, SUITE 200, #250 Charlotte NC NORTH CAROLINA 28277 Director L. Arthur Hewitt c/o Adaptin Bio, Inc. 3540 TORINGDON WAY, SUITE 200, #250 Charlotte NC NORTH CAROLINA 28277 Executive Officer Chief Development Officer Timothy Maness c/o Adaptin Bio, Inc. 3540 TORINGDON WAY, SUITE 200, #250 Charlotte NC NORTH CAROLINA 28277 Executive Officer Chief Financial Officer Simon Pedder c/o Adaptin Bio, Inc. 3540 TORINGDON WAY, SUITE 200, #250 Charlotte NC NORTH CAROLINA 28277 Executive Officer Director Executive Chairman Biotechnology Decline to Disclose 06b true 0001938571-26-000003 2025-12-22 false true false 0 Laidlaw & Company (UK) Ltd. 119037 None None 521 Fifth Avenue 12th Floor New York NY NEW YORK 10175 CA CALIFORNIA IL ILLINOIS KS KANSAS LA LOUISIANA MI MICHIGAN NJ NEW JERSEY NY NEW YORK NC NORTH CAROLINA OR OREGON SC SOUTH CAROLINA TX TEXAS false 4000000 1912000 2088000 false 19 229440 true 0 Based on total amount sold as of date of first sale. In addition to the sales commissions, warrants to purchase up to an aggregate of 80,000 shares of our common stock will be issued to the placement agent at the final closing. 0 Other than the payment of salaries and other compensation and benefits, no officer, director or promoter will receive any payments from the proceeds of this offering. false ADAPTIN BIO, INC. /s/ Michael J. Roberts Michael J. Roberts President and Chief Executive Officer 2026-06-22